NFKB1 and congestive heart failure: Given the involvement of miR-223 in cardiovascular inflammation and NF-κB’s role in pyroptosis, the miR-223/NF-κB axis has been proposed as a potential therapeutic target for modulating myocardial pyroptosis in CHF.